793 related articles for article (PubMed ID: 31029650)
21. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.
Eswaran SL; Chey WD; Han-Markey T; Ball S; Jackson K
Am J Gastroenterol; 2016 Dec; 111(12):1824-1832. PubMed ID: 27725652
[TBL] [Abstract][Full Text] [Related]
22. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
Bennet SMP; Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Öhman L; Simrén M
Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515
[TBL] [Abstract][Full Text] [Related]
23. Challenges of the low FODMAP diet for managing irritable bowel syndrome and approaches to their minimisation and mitigation.
Wilson B; Cox SR; Whelan K
Proc Nutr Soc; 2021 Feb; 80(1):19-28. PubMed ID: 32468985
[TBL] [Abstract][Full Text] [Related]
24. The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.
Chumpitazi BP
Curr Opin Gastroenterol; 2020 Mar; 36(2):147-154. PubMed ID: 31850930
[TBL] [Abstract][Full Text] [Related]
25. Re-challenging FODMAPs: the low FODMAP diet phase two.
Tuck C; Barrett J
J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():11-15. PubMed ID: 28244664
[TBL] [Abstract][Full Text] [Related]
26. Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.
Nordin E; Brunius C; Landberg R; Hellström PM
Am J Clin Nutr; 2022 Feb; 115(2):344-352. PubMed ID: 34617561
[TBL] [Abstract][Full Text] [Related]
27. Dietary practices and FODMAPs in South Asia: Applicability of the low FODMAP diet to patients with irritable bowel syndrome.
Hewawasam SP; Iacovou M; Muir JG; Gibson PR
J Gastroenterol Hepatol; 2018 Feb; 33(2):365-374. PubMed ID: 28700090
[TBL] [Abstract][Full Text] [Related]
28. The Low FODMAP Diet: Many Question Marks for a Catchy Acronym.
Catassi G; Lionetti E; Gatti S; Catassi C
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28300773
[TBL] [Abstract][Full Text] [Related]
29. Low-FODMAP Diet for Irritable Bowel Syndrome: What We Know and What We Have Yet to Learn.
Liu J; Chey WD; Haller E; Eswaran S
Annu Rev Med; 2020 Jan; 71():303-314. PubMed ID: 31986083
[TBL] [Abstract][Full Text] [Related]
30. A low fermentable oligo-di-mono saccharides and polyols (FODMAP) diet reduced pain and improved daily life in fibromyalgia patients.
Marum AP; Moreira C; Saraiva F; Tomas-Carus P; Sousa-Guerreiro C
Scand J Pain; 2016 Oct; 13():166-172. PubMed ID: 28850525
[TBL] [Abstract][Full Text] [Related]
31. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome.
Dionne J; Ford AC; Yuan Y; Chey WD; Lacy BE; Saito YA; Quigley EMM; Moayyedi P
Am J Gastroenterol; 2018 Sep; 113(9):1290-1300. PubMed ID: 30046155
[TBL] [Abstract][Full Text] [Related]
32. The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome.
Weynants A; Goossens L; Genetello M; De Looze D; Van Winckel M
J Hum Nutr Diet; 2020 Apr; 33(2):159-169. PubMed ID: 31637777
[TBL] [Abstract][Full Text] [Related]
33. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice.
Whelan K; Martin LD; Staudacher HM; Lomer MCE
J Hum Nutr Diet; 2018 Apr; 31(2):239-255. PubMed ID: 29336079
[TBL] [Abstract][Full Text] [Related]
34. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Schumann D; Klose P; Lauche R; Dobos G; Langhorst J; Cramer H
Nutrition; 2018 Jan; 45():24-31. PubMed ID: 29129233
[TBL] [Abstract][Full Text] [Related]
35. Group education on the low FODMAP diet improves gastrointestinal symptoms but neither anxiety or depression in irritable bowel syndrome.
Chan MMH; Zarate-Lopez N; Martin L
J Hum Nutr Diet; 2022 Jun; 35(3):425-434. PubMed ID: 34705305
[TBL] [Abstract][Full Text] [Related]
36. The role of FODMAPs in irritable bowel syndrome.
Shepherd SJ; Halmos E; Glance S
Curr Opin Clin Nutr Metab Care; 2014 Nov; 17(6):605-9. PubMed ID: 25255126
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis.
Black CJ; Staudacher HM; Ford AC
Gut; 2022 Jun; 71(6):1117-1126. PubMed ID: 34376515
[TBL] [Abstract][Full Text] [Related]
38. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
Cox SR; Lindsay JO; Fromentin S; Stagg AJ; McCarthy NE; Galleron N; Ibraim SB; Roume H; Levenez F; Pons N; Maziers N; Lomer MC; Ehrlich SD; Irving PM; Whelan K
Gastroenterology; 2020 Jan; 158(1):176-188.e7. PubMed ID: 31586453
[TBL] [Abstract][Full Text] [Related]
39. Diets that differ in their FODMAP content alter the colonic luminal microenvironment.
Halmos EP; Christophersen CT; Bird AR; Shepherd SJ; Gibson PR; Muir JG
Gut; 2015 Jan; 64(1):93-100. PubMed ID: 25016597
[TBL] [Abstract][Full Text] [Related]
40. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome.
Whigham L; Joyce T; Harper G; Irving PM; Staudacher HM; Whelan K; Lomer MC
J Hum Nutr Diet; 2015 Dec; 28(6):687-96. PubMed ID: 25871564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
